Literature DB >> 20881322

Neuropeptide Y is a mediator of chronic vascular and metabolic maladaptations to stress and hypernutrition.

Ken Abe1, Lydia Kuo, Zofia Zukowska.   

Abstract

Neuropeptide Y (NPY) is a central neuromodulator and peripheral sympathetic neurotransmitter that also has important regulatory roles in cardiovascular, neuroendocrine, immune and metabolic functions during stress. Focusing on the peripheral actions of the peptide in rodent models, we summarize recent studies from our laboratory demonstrating that stress-induced release of NPY mediates accelerated atherosclerosis/restenosis, obesity and metabolic-like syndrome, particularly when combined with a high fat, high sugar diet. In this review, we propose mechanisms of NPY's actions, its receptors and cellular substrates that increase the risk for cardiovascular and metabolic diseases when chronic stress is associated with pre-existing vascular injury and/or states of hypernutrition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881322     DOI: 10.1258/ebm.2010.009136

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  11 in total

1.  Gene expression profile in bone of diabetes-prone BB/OK rats fed a high-fat diet.

Authors:  Jörn Lange; Thomas Barz; Axel Ekkernkamp; Ingrid Klöting; Niels Follak
Journal:  Genes Nutr       Date:  2012-05-26       Impact factor: 5.523

Review 2.  NPY and stress 30 years later: the peripheral view.

Authors:  Dalay Hirsch; Zofia Zukowska
Journal:  Cell Mol Neurobiol       Date:  2012-01-24       Impact factor: 5.046

3.  Maternal low-protein diet up-regulates the neuropeptide Y system in visceral fat and leads to abdominal obesity and glucose intolerance in a sex- and time-specific manner.

Authors:  Ruijun Han; Aiyun Li; Lijun Li; Joanna B Kitlinska; Zofia Zukowska
Journal:  FASEB J       Date:  2012-04-25       Impact factor: 5.191

4.  Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue.

Authors:  Robina Matyal; Feroze Mahmood; Michael Robich; Hiliary Glazer; Kamal Khabbaz; Philip Hess; Cesario Bianchi; Robert Hagberg; Shu-Xu Hu; Frank W Sellke
Journal:  Eur J Pharmacol       Date:  2011-04-28       Impact factor: 4.432

Review 5.  Neuroimmunology of the atherosclerotic plaque: a morphological approach.

Authors:  Rita Businaro
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-14       Impact factor: 4.147

6.  Adaptogens stimulate neuropeptide y and hsp72 expression and release in neuroglia cells.

Authors:  Alexander Panossian; Georg Wikman; Punit Kaur; Alexzander Asea
Journal:  Front Neurosci       Date:  2012-02-01       Impact factor: 4.677

Review 7.  The nonglycemic actions of dipeptidyl peptidase-4 inhibitors.

Authors:  Na-Hyung Kim; Taeyang Yu; Dae Ho Lee
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

8.  Glucose intolerance after chronic stress is related with downregulated PPAR-γ in adipose tissue.

Authors:  Vitor H Pereira; Fernanda Marques; Vânia Lages; Filipa G Pereira; Alexandre Patchev; Osborne F X Almeida; Joana Almeida-Palha; Nuno Sousa; João J Cerqueira
Journal:  Cardiovasc Diabetol       Date:  2016-08-19       Impact factor: 9.951

9.  Stress hormone epinephrine enhances adipogenesis in murine embryonic stem cells by up-regulating the neuropeptide Y system.

Authors:  Ruijun Han; Joanna B Kitlinska; William R Munday; G Ian Gallicano; Zofia Zukowska
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

10.  Chronic stress: a crucial promoter of cell apoptosis in atherosclerosis.

Authors:  Ling-Bing Meng; Meng-Jie Shan; Ze-Mou Yu; Jian Lv; Ruo-Mei Qi; Peng Guo; Yuan-Meng Zhang; Tao Gong
Journal:  J Int Med Res       Date:  2019-01-31       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.